Literature DB >> 16556074

MicroRNAs as a potential magic bullet in cancer.

Frank J Slack1, Joanne B Weidhaas.   

Abstract

Genes that control cell differentiation and development are frequently mutated in human cancer. Micro (mi)RNAs are small regulatory RNAs that are emerging as important regulators of cell division/differentiation and human cancer genes. In this review, the miRNA cancer connection is discussed and the possibility of using this novel, but potentially powerful new therapy, involving miRNAs, to treat cancers is speculated on. For example, lung cancer is the major cause of cancer deaths in the USA, but existing therapies fail to treat this disease in the overwhelming majority of cases. The let-7 miRNA is one of a number of 'oncomirs', natural miRNA tumor suppressors in lung tissue, which may prove useful in treating lung cancer or enhancing current treatments for lung cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556074     DOI: 10.2217/14796694.2.1.73

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  29 in total

Review 1.  Small RNAs have a big impact on regeneration.

Authors:  Elizabeth J Thatcher; James G Patton
Journal:  RNA Biol       Date:  2010-05-14       Impact factor: 4.652

Review 2.  New trends in molecular and cellular biomarker discovery for colorectal cancer.

Authors:  Parisa Aghagolzadeh; Ramin Radpour
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

3.  Isolation of microarray-grade total RNA, microRNA, and DNA from a single PAXgene blood RNA tube.

Authors:  Mogens Kruhøffer; Lars Dyrskjøt; Thorsten Voss; Raija L P Lindberg; Ralf Wyrich; Thomas Thykjaer; Torben F Orntoft
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

Review 4.  MicroRNAs in brain function and disease.

Authors:  Andreas Walter Kuss; Wei Chen
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

5.  MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells.

Authors:  Hung-Hua Liang; Po-Li Wei; Chin-Sheng Hung; Chun-Te Wu; Weu Wang; Ming-Te Huang; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2013-06-13

6.  Biologic characteristics of premalignant breast disease.

Authors:  Kimberly Cole; Maria Tabernero; Karen S Anderson
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

7.  MicroRNA signatures differentiate uterine cancer tumor subtypes.

Authors:  Elena S Ratner; David Tuck; Christine Richter; Sunitha Nallur; Rajeshvari M Patel; Vince Schultz; Pei Hui; Peter E Schwartz; Thomas J Rutherford; Joanne B Weidhaas
Journal:  Gynecol Oncol       Date:  2010-06-09       Impact factor: 5.482

8.  The KRAS-Variant Genetic Test As a Marker of Increased Risk of Ovarian Cancer.

Authors:  Florence K Keane; Elena S Ratner
Journal:  Rev Obstet Gynecol       Date:  2010

9.  Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer.

Authors:  Kwang-Hyuck Lee; Craig Lotterman; Collins Karikari; Noriyuki Omura; Georg Feldmann; Nils Habbe; Michael G Goggins; Joshua T Mendell; Anirban Maitra
Journal:  Pancreatology       Date:  2009-04-29       Impact factor: 3.996

10.  RNA interference and micro RNA-oriented therapy in cancer: rationales, promises, and challenges.

Authors:  T F Duchaine; F J Slack
Journal:  Curr Oncol       Date:  2009-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.